CJC-1295-Ipamorelin

CJC-1295 and Ipamorelin are synthetic peptides studied in laboratory research for their interactions with growth hormone–related signaling pathways. CJC-1295 is a modified GHRH analogue, while Ipamorelin is a selective growth hormone secretagogue investigated for ghrelin receptor-related activity. Their combination may be evaluated in controlled research systems to examine peptide interactions, receptor signaling, and related biochemical responses. Strictly for laboratory research use only — not intended for human or veterinary use, therapeutic applications, or diagnostic purposes.